Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds
Fierce Pharma
Fri, 08/23/24 - 10:55 am
FDA
stomach cancer
Bristol Myers Squibb
Opdivo
Yervoy
Merck
Keytruda
BeiGene
Tevimbra
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO
Reuters
Thu, 08/22/24 - 10:01 pm
Zenas BioPharma
IPOs
Bristol Myers Squibb
BMS eyes April FDA verdict on Opdivo/Yervoy in liver cancer
Pharmaphorum
Thu, 08/22/24 - 11:09 am
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
FDA
BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings
Pharma Voice
Mon, 08/19/24 - 09:58 am
Bristol Myers Squibb
KarXT
FDA
schizophrenia
AbbVie
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
Bristol Myers cited by FDA for misleading claims on Krazati website
Seeking Alpha
Wed, 08/7/24 - 11:11 pm
Bristol Myers Squibb
FDA
OPDP
Krazati
Bristol Myers telegraphs layoffs in New Jersey, trimming 117 jobs in staggered wave of cuts
Fierce Pharma
Mon, 08/5/24 - 11:14 pm
Bristol Myers Squibb
New Jersey
layoffs
restructuring
BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific
Fierce Biotech
Mon, 08/5/24 - 11:10 am
Bristol Myers Squibb
Tigit
Agenus
bispecific antibodies
3 Big Pharma cancer drugs facing inflation penalties
Pharma Voice
Wed, 07/31/24 - 10:27 am
inflation
Inflation Reduction Act
drug pricing
Abecma
Breyanzi
Bristol Myers Squibb
Pfizer
Adcetris
Astellas
Padcev
cancer
BMS Gets Q2 Beat, Raises Full-Year Guidance as Cost-Cutting Initiative Continues
BioSpace
Fri, 07/26/24 - 11:06 am
Bristol Myers Squibb
earnings
Aveo spins a silver lining in failed trial of kidney cancer drug Fotivda
Fierce Pharma
Thu, 07/18/24 - 11:06 pm
Aveo Oncology
kidney cancer
Fotivda
Opdivo
Bristol Myers Squibb
J&J, BMS and AstraZeneca strike back in appeals after IRA litigation losses
Fierce Pharma
Tue, 07/16/24 - 12:00 pm
Inflation Reduction Act
Medicare
drug pricing
JNJ
Bristol Myers Squibb
AstraZeneca
BMS’ long-standing leukemia blockbuster stares down its first generic
Pharma Voice
Fri, 07/12/24 - 11:10 am
Bristol Myers Squibb
Sprycel
leukemia
generics
CML
Xspray Pharma
BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival
Fierce Biotech
Mon, 07/1/24 - 11:29 am
Bristol Myers Squibb
Eisai
antibody-drug conjugate
Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
Pharma Voice
Fri, 06/28/24 - 11:17 am
Big Pharma
Neuroscience
Prothena Biosciences
Biogen
Eisai
Pfizer
AbbVie
Eli Lilly
Bristol Myers Squibb
How Pfizer, Bristol Myers Squibb and Johnson & Johnson Are Confronting Patent Cliffs
BioSpace
Wed, 06/26/24 - 09:54 am
patents
Pfizer
Bristol Myers Squibb
JNJ
patent cliffs
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Adaptimmune
afami-cel
advanced synovial sarcoma
Lykos Therapeutics
MDMA
PTSD
Bristol Myers Squibb
KarXT
schizophrenia
Daiichi Sankyo
AstraZeneca
Dato-DXd
non-small cell lung cancer
BMS gets FDA approval for Krazati in colorectal cancer
Pharmaphorum
Mon, 06/24/24 - 10:50 am
Bristol Myers Squibb
FDA
Krazati
colorectal cancer
FDA approves new Augtyro indication for NTRK-positive tumors
Investing.com
Thu, 06/13/24 - 11:12 pm
Bristol Myers Squibb
Augtyro
FDA
solid tumors
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »